Houston Medical Times

Page 1

Serving Harris, Brazoria, Fort Bend, Montgomery and Galveston Counties

HOUSTON

Volume 11 | Issue 9

Inside This Issue

September Edition 2021

National Covid-19 Transmission Study Expands to Houston Area By Dee Dee Grays PreventCOVIDU study aims to determine how effect vaccines are at preventing infection and transmission of COVID-19 virus

H Chris Osentowski named chief executive officer of HCA Houston Healthcare Medical Center See pg. 10

INDEX Legal Matters........................ pg.3 Oncology Research......... pg.5 The Framework.................... pg.7 Healthy Heart....................... pg.8 Financial Forecast.............pg.11

ouston residents can now take part in a national study evaluating the spread of SARS-CoV-2 in young adults. Texas A&M University Health Science Center (Texas A&M Health) has expanded participation in the PreventCOVIDU study to include the Houston area. The study involving thousands of young adults across the United States aims to determine whether individuals who have received the Moderna COVID-19 vaccine can still spread the coronavirus to others. The COVID-19 Prevention Network (CoVPN), headquartered at Fred Hutchinson Cancer Research Center, launched the study in March following an announcement from the White House. Researchers from Texas A&M Health are involved in enrolling participants and collecting data for the study. They have been recruiting in Bryan-College Station and Kingsville since the study launched and hope that by expanding to Houston they will reach or exceed their goal of enrolling at least 2000 young adults in Texas ages 18-29. This is the first study

of this kind to thoroughly evaluate the effectiveness of the vaccine on SARS-CoV-2 infection, how infectious a person with the virus may be, and transmission of the virus to others.

study, we can start answering these questions in the next few months.” The researchers in this study want to learn if the vaccine protects people from becoming infected with SARS-CoV-2, and if the vaccine prevents individuals from transmitting SARS-CoV-2 to others. This randomized, open-label controlled study will involve 18,000 young people throughout the United States. Participants will be offered the Moderna COVID-19 vaccine as part of the study, but vaccination is not required to take part. Half of the participants who receive the vaccine will be randomly selected to be vaccinated as soon as they enroll in the study, and the other half will receive the vaccine later during the study. Individuals who prefer not to receive the vaccine are also able to participate, acting as a control group. Texas A&M is the only institution in Texas participating in this national study, and Texas is leading the nation in participation, which means young adults who enroll

Young adults who have not yet been vaccinated and have never had COVID-19 are invited ...to join this study, participants ... could receive up to $1,000 over four months while taking part in the study.

Empower Pharmacy Opens North America’s Most Advanced Compounding Pharmacy in Houston See pg. 12

“This is an incredible opportunity for young adults to be part of something big,” said principal investigator Rebecca Fischer, PhD, MPH, DTM&H, a professor at Texas A&M School of Public Health. “The scientific evidence we build through this historic effort will help answer some of the most important questions the world has at this moment about how vaccines work to prevent infections in a real-world scenario. We know the vaccines are incredibly effective at preventing disease, hospitalizations, and deaths. We hope to learn whether they can also block infections and prevent transmission. Through this

see Study..page 14

PRSRT STD US POSTAGE PAID PERMIT NO 1 HOUSTON TX


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.
Houston Medical Times by Rick Delarosa - Issuu